We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$11.4B
AUM Growth
-$318M
Cap. Flow
+$3.49M
Cap. Flow %
0.03%
Top 10 Hldgs %
29.99%
Holding
100
New
2
Increased
15
Reduced
62
Closed
2

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.8M
2
GSK icon
GSK
GSK
+$48.1M
3
TECK icon
Teck Resources
TECK
+$21.6M
4
AVNS
Avanos Medical
AVNS
+$6.39M
5
CVE icon
Cenovus Energy
CVE
+$4.92M

Sector Composition

Rank Sector Weight
1 Financials 22.78%
2 Energy 19.58%
3 Communication Services 12.9%
4 Technology 8.07%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SU icon
1
Suncor Energy
SU
$79.4B
$442M 3.86%
13,886,777
-65,442
-0.5% -$2.16M
CNQ icon
2
Canadian Natural Resources
CNQ
$99.4B
$430M 3.76%
28,720,739
-116,563
-0.4% -$1.9M
MFC icon
3
Manulife Financial
MFC
$73.9B
$361M 3.16%
18,876,300
-230,525
-1% -$4.36M
SLF icon
4
Sun Life Financial
SLF
$46B
$356M 3.11%
9,848,330
-187,426
-2% -$6.7M
BMO icon
5
Bank of Montreal
BMO
$126B
$353M 3.08%
4,977,391
-90,227
-2% -$6.46M
TU icon
6
Telus
TU
$14.9B
$341M 2.98%
18,871,878
-89,190
-0.5% -$1.61M
BCE icon
7
BCE
BCE
$20.2B
$314M 2.74%
6,827,348
-54,606
-0.8% -$2.45M
TRI icon
8
Thomson Reuters
TRI
$42.8B
$292M 2.55%
6,229,945
-184,976
-3% -$8.19M
TD icon
9
Toronto Dominion Bank
TD
$198B
$284M 2.48%
5,929,417
-84,230
-1% -$4.06M
BAC icon
10
Bank of America
BAC
$435B
$259M 2.26%
14,470,261
-93,225
-0.6% -$1.6M
C icon
11
Citigroup
C
$222B
$251M 2.19%
4,631,183
-21,865
-0.5% -$1.16M
GE icon
12
GE Aerospace
GE
$374B
$248M 2.17%
2,051,636
-9,786
-0.5% -$1.2M
RY icon
13
Royal Bank of Canada
RY
$291B
$246M 2.16%
3,563,407
-48,294
-1% -$3.42M
VZ icon
14
Verizon
VZ
$195B
$245M 2.14%
5,234,744
+96,257
+2% +$4.71M
RDS.A
15
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$242M 2.11%
3,608,475
-11,200
-0.3% -$775K
RCI icon
16
Rogers Communications
RCI
$18.3B
$240M 2.1%
6,175,221
-31,925
-0.5% -$1.23M
COP icon
17
ConocoPhillips
COP
$147B
$235M 2.06%
3,403,900
-5,395
-0.2% -$377K
CSCO icon
18
Cisco
CSCO
$457B
$220M 1.93%
7,916,863
-158,550
-2% -$4.09M
TLM
19
DELISTED
TALISMAN ENERGY INC
TLM
$219M 1.92%
27,936,199
-1,967,125
-7% -$12.4M
CLS icon
20
Celestica
CLS
$38.1B
$219M 1.91%
18,605,268
-109,925
-0.6% -$1.18M
T icon
21
AT&T
T
$159B
$218M 1.91%
8,610,311
+111,746
+1% +$2.9M
MGA icon
22
Magna International
MGA
$18.7B
$214M 1.87%
3,940,694
+29,744
+0.8% +$1.5M
PFE icon
23
Pfizer
PFE
$143B
$208M 1.82%
7,044,657
-88,734
-1% -$2.54M
AGU
24
DELISTED
Agrium
AGU
$199M 1.74%
2,095,760
-2,650
-0.1% -$248K
WMT icon
25
Walmart Inc
WMT
$885B
$193M 1.69%
6,746,742
-70,575
-1% -$1.91M

Similar funds

Letko, Brosseau & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Letko, Brosseau & Associates held 100 positions worth $11.4B, down 2.7% from $11.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 4%. Letko, Brosseau & Associates opened 2 new positions and exited 2, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q4 2014 buy was Avanos Medical: 162,551 shares worth $7.39M.
  • Letko, Brosseau & Associates added most to Gilead Sciences in Q4 2014, an estimated $61.8M increase.
  • Letko, Brosseau & Associates's biggest Q4 2014 reduction was TALISMAN ENERGY INC, cutting an estimated $12.4M.
  • Letko, Brosseau & Associates fully exited AstraZeneca in Q4 2014, selling an estimated $37M.
  • Letko, Brosseau & Associates's ten largest holdings make up 30% of its $11.4B portfolio in Q4 2014.
  • Letko, Brosseau & Associates opened 2 new positions and closed 2 in Q4 2014.
  • Letko, Brosseau & Associates's portfolio value fell 2.7% quarter-over-quarter to $11.4B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2014, filed 10 Feb 2015.